Addrenex Pharmaceuticals Expands Product Pipeline by Licensing New Drug to Treat Narcolepsy
...nter phase 2 trials. In addition to drug development, SK Life Science Business focuses on the custom manufacturing of pharmaceutical intermediates and api with unique and cost-effective technologies, including continuous reactions and low-temperature reactions. ...Glenmark Initiates Phase 2 Trial for Crofelemer for Acute Infectious Diarrhea
...felemer for these indications. Glenmark is the manufacturer of crofelemer api (active pharmaceutical ingredient) for Napo's current Phase 3 trial for cro...ammation and metabolic disorders. The Company has generic formulation and api business interests in over 80 countries across the world including the high...